quinacrine has been researched along with Hemorrhage in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Hemorrhage: Bleeding or escape of blood from a vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We used intrapleural instillation of quinacrine hydrochloride in 20 patients (Group A) with recurrent spontaneous pneumothorax (one bilateral) and compared their clinical course with 19 patients who underwent thoracotomy and scarification or pleurectomy (Group B) and 63 patients treated by tube thoracostomy alone (Group C)." | 7.66 | Intrapleural instillation of quinacrine for treatment of recurrent spontaneous pneumothorax. ( Derrick, JR; Larrieu, AJ; O'Neill, MJ; Tyers, GF; Williams, EH, 1979) |
| "We used intrapleural instillation of quinacrine hydrochloride in 20 patients (Group A) with recurrent spontaneous pneumothorax (one bilateral) and compared their clinical course with 19 patients who underwent thoracotomy and scarification or pleurectomy (Group B) and 63 patients treated by tube thoracostomy alone (Group C)." | 3.66 | Intrapleural instillation of quinacrine for treatment of recurrent spontaneous pneumothorax. ( Derrick, JR; Larrieu, AJ; O'Neill, MJ; Tyers, GF; Williams, EH, 1979) |
| "In ET, thrombosis was associated with JAK2V617F mutation (p < 0." | 1.40 | JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients. ( Almeida Santos, S; Bento, C; Caetano, G; Coucelo, M; Duarte, M; Fidalgo, T; Fortuna, M; Menezes, C; Ribeiro, ML; Sevivas, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coucelo, M | 1 |
| Caetano, G | 1 |
| Sevivas, T | 1 |
| Almeida Santos, S | 1 |
| Fidalgo, T | 1 |
| Bento, C | 1 |
| Fortuna, M | 1 |
| Duarte, M | 1 |
| Menezes, C | 1 |
| Ribeiro, ML | 1 |
| Larrieu, AJ | 1 |
| Tyers, GF | 1 |
| Williams, EH | 1 |
| O'Neill, MJ | 1 |
| Derrick, JR | 1 |
2 other studies available for quinacrine and Hemorrhage
| Article | Year |
|---|---|
JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Blood Platelets; Case-Control Studies; CD11b Antigen; Codon | 2014 |
Intrapleural instillation of quinacrine for treatment of recurrent spontaneous pneumothorax.
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Hemorrhage; Humans; Intubation; Male; Mid | 1979 |